Cytarabine/Fludarabine/Oxaliplatin/Rituximab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of cytarabine, fludarabine, oxaliplatin and rituximab that may be used in the treatment of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).

**Synonyms:** - Cytarabine-Fludarabine-Oxaliplatin-Rituximab - Cytarabine/Fludarabine/Oxaliplatin/Rituxan - Cytarabine/Fludarabine/Oxaliplatin/Rituximab - OFAR - OFAR - OFAR (rituximab-abbs) - OFAR (rituximab-arrx) - OFAR (rituximab-blit) - OFAR (rituximab-pvvr) - OFAR (rituximab-rite) - OFAR (rituximab-rixa) - OFAR (rituximab-rixi) - Oxaliplatin/Fludarabine/Cytarabine/Rituximab